Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award
A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a version of...To view the full article, register now.
Already a subscriber? Click here to view full article